John Phillips
Radiation Oncology · Nashville, TNNPI 1154648426
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $18,250 of the $23,281 with a category attached, or 78.4%. Monteris Medical Corporation accounts for 75.6% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $14,261 and has fallen 91.5% since, to $1,213 in 2025. Among radiation oncology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 49 payments — averaging $475.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Monteris Medical Corporation$18K
- Novartis$3K
- Janssen Scientific Affairs, LLC$566
- Reflexion Medical, Inc.$524
- AstraZeneca$378
- Siemens Medical Solutions USA, Inc.$222
- plus $797 from 7 others
What the payments were for
- Consulting fees$18,25078%
- Travel & lodging$2,0989%
- Food & beverage$2,93313%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Monteris Medical Corporation | 23 | $17,594 |
| Novartis | 6 | $3,200 |
| Janssen Scientific Affairs, LLC | 4 | $566 |
| Reflexion Medical, Inc. | 2 | $524 |
| AstraZeneca | 3 | $378 |
| Siemens Medical Solutions USA, Inc. | 4 | $222 |
| Palette Life Sciences, Inc. | 1 | $136 |
| Boston Scientific | 1 | $134 |
| Exelixis Inc. | 1 | $130 |
| Brainlab, Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $118 |
| Dendreon Pharmaceuticals LLC | 1 | $102 |
| Johnson & Johnson | 1 | $52 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Neuroblate$17,519
- Erleada$566
- REFLEXION MEDICAL RADIOTHERAPY SYSTEM$524
- LYNPARZA$378
- Pipeline$150
- AKEEGA$143
- SpaceOAR VUE System - 10mL$134
- Cabometyx$130
- Image Guided Surgical Device$125
- LIBTAYO$118
- Varian Ethos Treatment Planning$113
- PROVENGE$102
How this compares
$23,281 in reported general payments places this provider in the 95th percentile of 115 radiation oncology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 16 | $304 |
| Mometasone Furoate | 11 | $107 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Nashville
- Han-Chih ChangNashville$66K
- Karen WinkfieldNashville$53K
- James GrayNashville$46K
- Casey LipscombNashville$23K
- Andrew KennedyNashville$18K
- Anthony CmelakNashville$16K
- Evan OsmundsonNashville$8K
- Joshua MondscheinNashville$6K
- Diandra Ayala-PeacockNashville$4K
- Ryan JonesNashville$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.